مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,074
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

THE EFFECT OF CAPTOPRIL ON HEMATOCRIT OF DIALYSIS PATIENTS RECEIVING SYNTHETIC ERYTHROPOIETIN

Pages

  79-86

Abstract

 Angiotensin converting enzyme (ACE) drugs like CAPTOPRIL are proposed as a resistant factor against the effect of erythropoietin. As these groups are used as a choice to treat hypertension, so conducting more studies with regard to their effects on erythropoietin efficacy is important. This interventional study was performed on 19 patients with chronic hemodialysis. Patients were divided into two groups; 9 cases received the low dose CAPTOPRIL (6.25% mg/daily) and 10 cases received high dose (25mg/TDS). None of the patients had any acute inflammatory or infectious process, iron deficiency and other causes of ANEMIA at the time of study. They were followed for 3 months and their HEMATOCRIT was measured before intervention at the end of the first, the second and the third months. Erythropoietin dose was constant during 3 months. To analyse the data, Wilcoxon and Mann-Whitney tests were used with the significant level of 5%. The mean of HEMATOCRIT changes in patients with low dose CAPTOPRIL was 1.1 in the first month with standard deviation (SD) of 3.07 (P=0.325), in the second month 1.46 with SD of 3.42 (P=0.27) and in the third month was 0.9 with SD of 4.44 (P=0.495). None of the changes was statistically significant. The mean of changes in cases with high dose CAPTOPRIL was 1.45 in the first month with SD of 3.76 (P=0.26), in the second month 1.40 with SD of 4.76 (P=0.528) and in the third month was 0.87 with SD of 4.79 (P=0.838). In this group, none of the changes was statistically significant. In conclusion, it seems CAPTOPRIL with high and low doses of treatment does not reduce HEMATOCRIT in the HEMODIALYSIS PATIENTS receiving the SYNTHETIC ERYTHROPOIETIN.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    SAMIEE, M., DAVACHI, F., & GHORBANI, R.. (2005). THE EFFECT OF CAPTOPRIL ON HEMATOCRIT OF DIALYSIS PATIENTS RECEIVING SYNTHETIC ERYTHROPOIETIN. RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES), 12(45), 79-86. SID. https://sid.ir/paper/11179/en

    Vancouver: Copy

    SAMIEE M., DAVACHI F., GHORBANI R.. THE EFFECT OF CAPTOPRIL ON HEMATOCRIT OF DIALYSIS PATIENTS RECEIVING SYNTHETIC ERYTHROPOIETIN. RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES)[Internet]. 2005;12(45):79-86. Available from: https://sid.ir/paper/11179/en

    IEEE: Copy

    M. SAMIEE, F. DAVACHI, and R. GHORBANI, “THE EFFECT OF CAPTOPRIL ON HEMATOCRIT OF DIALYSIS PATIENTS RECEIVING SYNTHETIC ERYTHROPOIETIN,” RAZI JOURNAL OF MEDICAL SCIENCES (JOURNAL OF IRAN UNIVERSITY OF MEDICAL SCIENCES), vol. 12, no. 45, pp. 79–86, 2005, [Online]. Available: https://sid.ir/paper/11179/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button